Sapropterin, also known as tetrahydrobiopterin, is a cofactor for aromatic amino acid hydroxylase enzymes. It plays a critical role in the degradation of phenylalanine and the biosynthesis of neurotransmitters, such as dopamine and serotonin. Sapropterin is commonly used as an adjunctive treatment for phenylketonuria (PKU) to help lower blood phenylalanine levels in patients with hyperphenylalaninemia. It is sold under the brand name Kuvan.
Parent: Sapropterin
Parent: Sapropterin/ Sapropterin Dihydrochloride
Parent: Sapropterin / Dihydrochloride
Parent: Sapropterin
Parent: Sapropterin
Parent: Sapropterin/ Biopterin
Parent: Sapropterin
Parent: Sapropterin
Parent: Sapropterin
Parent: Sapropterin / Dihydrochloride
Parent: Sapropterin
Impurities in sapropterin may arise during its synthesis, handling, or storage. Controlling these impurities is essential to ensure the medication’s efficacy, stability, and safety.
Related Substances
These are byproducts or intermediates formed during the synthesis of sapropterin. Regulatory authorities set strict limits on these impurities to ensure drug purity.
Degradation Products
Sapropterin can degrade when exposed to light, moisture, or heat, potentially reducing its effectiveness. Proper storage in a cool, dry place is essential to maintain stability.
Residual Solvents
Trace amounts of solvents used during manufacturing may remain in the final product. These are regulated to ensure they are within permissible safety limits.
Analytical Techniques for Monitoring Impurities
Techniques like High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (LC-MS) are used to identify and quantify impurities in sapropterin formulations.
Sapropterin works as a cofactor for the enzyme phenylalanine hydroxylase (PAH), which converts phenylalanine into tyrosine. By enhancing PAH activity, sapropterin helps lower blood phenylalanine levels in patients with phenylketonuria (PKU).
Yes, sapropterin is approved as a treatment for phenylketonuria (PKU). It is used in patients with a deficiency or reduced activity of phenylalanine hydroxylase to help lower phenylalanine levels in the blood.
Sapropterin belongs to the class of enzyme cofactors. It is a synthetic form of tetrahydrobiopterin (BH4), which is required for proper enzyme function in the metabolism of phenylalanine.
Sapropterin acts as a pharmacologic chaperone for phenylalanine hydroxylase, stabilizing and enhancing its activity. This allows for improved conversion of phenylalanine to tyrosine, thereby reducing blood phenylalanine levels in patients with PKU.
